About The Institute of Medical Science, The University of Tokyo
東京大学医科学研究所附属病院は、東京都港区白金台にある医療機関。東京大学医科学研究所附属の病院である。東京大学白金キャンパスの医科研敷地内にある。医育機関とは一線を画する医療を行う。略称医科研病院。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Tokyo University
8
Daiichi Sankyo Co., Ltd.
1
Pfizer
1
Takara Bio Inc.
1
Clinical Trials at The Institute of Medical Science, The University of Tokyo
During the past decade, The Institute of Medical Science, The University of Tokyo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee
2008-06-06
2009-12-25
Completed
83
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer
2008-05-01
2009-04-01
Unknown status
14
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer
2008-05-01
2009-04-01
Unknown status
14
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
2008-05-01
2009-03-01
Terminated
14
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer
2008-05-01
2009-05-01
Terminated
1
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer
2008-05-01
2009-03-01
Terminated
14
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer
2008-05-01
2009-03-01
Terminated
14
Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
2008-05-01
2009-05-01
Terminated
2
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The Institute of Medical Science, The University of Tokyo"
#1 collaborator was "Human Genome Center, Institute of Medical Science, University of Tokyo" with 8 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at The Institute of Medical Science, The University of Tokyo
According to Clinical.Site data, the most researched conditions in "The Institute of Medical Science, The University of Tokyo" are
"Breast Cancer" (2 trials), "Colon Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Non Small Cell Lung Cancer" (2 trials) and "Pancreas Neoplasms" (2 trials). Many other conditions were trialed in "The Institute of Medical Science, The University of Tokyo" in a lesser frequency.
Clinical Trials Intervention Types at The Institute of Medical Science, The University of Tokyo
Most popular intervention types in "The Institute of Medical Science, The University of Tokyo" are "Biological" (9 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "VEGFR1 and VEGFR2" (2 trials), "DS-3201b" (1 trials), "HLA-A*02:01-restricted VEGFR1-derived peptide vaccination" (1 trials), "PF-04383119 (tanezumab)" (1 trials) and "RNF43, TOMM34, VEGFR1 and VEGFR2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Institute of Medical Science, The University of Tokyo
The vast majority of trials in "The Institute of Medical Science, The University of Tokyo" are
11 trials for "All" genders.
Clinical Trials Status at The Institute of Medical Science, The University of Tokyo
Currently, there are NaN active trials in "The Institute of Medical Science, The University of Tokyo".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in The Institute of Medical Science, The University of Tokyo,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in The Institute of Medical Science, The University of Tokyo, 10 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".